VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
TAKAHASHI, KOICHI
One or more keywords matched the following items that are connected to
TAKAHASHI, KOICHI
Item Type
Name
Concept
Proto-Oncogene Proteins c-myc
Concept
Oncogene Proteins, Fusion
Concept
Proto-Oncogene Proteins c-bcl-2
Concept
Oncogene Protein p55(v-myc)
Concept
Proto-Oncogene Proteins p21(ras)
Concept
Proto-Oncogene Proteins
Academic Article
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.
Academic Article
t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.
Academic Article
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Academic Article
MYC protein expression is an important prognostic factor in acute myeloid leukemia.
Academic Article
PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia-initiating cells.
Academic Article
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Academic Article
Mechanistic basis and efficacy of targeting the ?-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.
Academic Article
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia.
Academic Article
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.
Academic Article
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
Academic Article
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Academic Article
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1-2 study.
Academic Article
[Novel therapies in AML and their resistance mechanisms].
Academic Article
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Academic Article
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.
Academic Article
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Academic Article
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Search Criteria
Oncogene Protein
p55 v myc